article
<b>Introduction:</b> Acute exacerbations of bronchiectasis (AEB) are a frequent complication of the disease. However, the factors related to non-invasive ventilation (NIV) in AEB are not well known. The aim of our study was to identify the predisposing factors to the use of NIV during AEB. <b>Methods:</b> A retrospective study including 120 patients hospitalized in the pneumology department D of A. Mami Hospital in Ariana for AEB between 2015 and 2021. Patients were divided into two groups according to the indication of NIV during the AEB:G1 with NIV(n=21),G2 without NIV(n=99). <b>Results:</b> Our population consisted of 88 women and 32 men, with a mean age of 62,8±14,6 years. No significant difference between the two groups regarding age(0,5),sex(0,4),smoking history(0,7) and comorbidities: Hight blood pressure(p=1),diabetes(p=0,1) and heart failure(p=0,8). The use of NIV during AEB was correlated with the paO2(54,13±5,32 in G1 Vs 72,69±13,87mmHg in G2,p=0,00), the paCO2(50,57±11,14 in G1 Vs 37,66±7,77mmHg in G2,p=0,00) the pH(7,38±0,05 in G1 Vs 7,42±0,41 in G2,p=0,003) and the number of lobes affected by Bronchiectasis(p=0,02). The length of hospital stay was significantly longer in patients requiring NIV(17,90±4,91in G1 Vs 11,61±6,64 days in G2,p=0,001). NIV use was significantly associated with the number of exacerbations per year (2,81±0,814 in G1 Vs 1,90±0,763 in G2,p=0,001) and the number of exacerbations requiring intensive care hospitalization(p=0,05). A significant correlation was noted between the use of NIV during AEB and the use of long-term oxygen therapy(p=0,001). <b>Conclusion:</b> Our study showed that the use of NIV during AEB was related to the extent of the disease and to the severity of clinical presentation.
This page summarises published work. The authoritative version sits with the publisher.
DOI: 10.1183/13993003.congress-2023.pa2847
Is something wrong with this record? Report it or request removal.
Discussion
Have you built on this work, tried to replicate it, or seen it applied in practice? Share what you know. Verified researchers and MARATTO™ domain experts can open a discussion, and any member can reply. Contributions are reviewed before they appear.
No discussion yet. Open the first thread.
New to MARATTO™? Create a free account.